These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10846395)

  • 1. [Surfactant proteins A and D as biomarkers of disease activity in diffuse interstitial pneumonia].
    Abe S; Takahashi H
    Nihon Kokyuki Gakkai Zasshi; 2000 Mar; 38(3):157-65. PubMed ID: 10846395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of serum surfactant proteins A and D in idiopathic interstitial pneumonia].
    Honda Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():181-5. PubMed ID: 9216212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
    Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I
    Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.
    Ohnishi H; Yokoyama A; Kondo K; Hamada H; Abe M; Nishimura K; Hiwada K; Kohno N
    Am J Respir Crit Care Med; 2002 Feb; 165(3):378-81. PubMed ID: 11818324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of levels of lung surfactant protein A in serum, in various lung diseases].
    Abe S; Honda Y; Ando M; Saita N; Kida K; Jinno S; Kondo A; Kuroki Y; Akino T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1219-25. PubMed ID: 8583713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis.
    Takahashi H; Kuroki Y; Tanaka H; Saito T; Kurokawa K; Chiba H; Sagawa A; Nagae H; Abe S
    Am J Respir Crit Care Med; 2000 Jul; 162(1):258-63. PubMed ID: 10903251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
    Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
    Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New serum markers to monitor treatment of acute exacerbation of interstitial lung disease].
    Otsuka M; Takahashi H; Fujisima T; Nishiyama K; Kon H; Outi H; Imai Y; Sakon O; Shiratori M; Abe S
    Nihon Kokyuki Gakkai Zasshi; 2001 Apr; 39(4):298-302. PubMed ID: 11481832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of serum surfactant protein-D (SP-D) level in patients with pulmonary tuberculosis].
    Kondo A; Oketani N; Maruyama M; Taguchi Y; Yamaguchi Y; Miyao H; Mashima I; Oono M; Wada K; Tsuchiya T; Takahashi H; Abe S
    Kekkaku; 1998 Oct; 73(10):585-90. PubMed ID: 9844346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent.
    Takahashi H; Fujishima T; Koba H; Murakami S; Kurokawa K; Shibuya Y; Shiratori M; Kuroki Y; Abe S
    Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):1109-14. PubMed ID: 10988138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary surfactant proteins SP-A and SP-D].
    Kuroki Y; Takahashi H
    Nihon Rinsho; 1999 Aug; 57 Suppl():309-12. PubMed ID: 10503429
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids.
    Honda Y; Kuroki Y; Matsuura E; Nagae H; Takahashi H; Akino T; Abe S
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1860-6. PubMed ID: 8520747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symposium on molecular pathogenesis of respiratory diseases and its clinical implication. 1. Diffuse infiltrative lung disease--new clinical biomarker in diffuse interstitial pneumonia.
    Abe S; Takahashi H
    Intern Med; 2001 Feb; 40(2):159-62. PubMed ID: 11300154
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
    Asano Y; Ihn H; Yamane K; Yazawa N; Kubo M; Fujimoto M; Tamaki K
    Arthritis Rheum; 2001 Jun; 44(6):1363-9. PubMed ID: 11407696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of severe Legionella pneumonia monitored with serum SP-A, SP-D, and KL-6].
    Sukoh N; Yamamoto H; Kikuchi E; Suzuki T; Kamimura A; Watanabe N; Takahashi H; Abe S; Tateda K
    Nihon Kokyuki Gakkai Zasshi; 2001 Feb; 39(2):126-30. PubMed ID: 11321824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of serum pulmonary surfactant proteins a and d for the early detection of radiation pneumonitis.
    Sasaki R; Soejima T; Matsumoto A; Maruta T; Yamada K; Ota Y; Kawabe T; Nishimura H; Sakai E; Ejima Y; Sugimura K
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):301-7. PubMed ID: 11380215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant appearance of lung surfactant protein A in sera of patients with idiopathic pulmonary fibrosis and its clinical significance.
    Honda Y; Kuroki Y; Shijubo N; Fujishima T; Takahashi H; Hosoda K; Akino T; Abe S
    Respiration; 1995; 62(2):64-9. PubMed ID: 7784711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis.
    Kuroki Y; Tsutahara S; Shijubo N; Takahashi H; Shiratori M; Hattori A; Honda Y; Abe S; Akino T
    Am Rev Respir Dis; 1993 Mar; 147(3):723-9. PubMed ID: 8442609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis.
    Greene KE; King TE; Kuroki Y; Bucher-Bartelson B; Hunninghake GW; Newman LS; Nagae H; Mason RJ
    Eur Respir J; 2002 Mar; 19(3):439-46. PubMed ID: 11936520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in-house ELISA method for measuring surfactant protein A.
    Cheong KB; Cheong SK; Boo NY; Jemilah M; Ton SH
    Malays J Pathol; 1995 Dec; 17(2):91-6. PubMed ID: 8935133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.